As civil society organizations concerned with ensuring prompt availability of affordable medicines in Least Developed Countries (LDCs) we call on World Trade Oorganization (WTO) Members to unconditionally accord the LDC Group an extension of the transition period with respect to pharmaceutical products and waivers from obligations under Article 70.8 (mailbox obligation) and Article70.9 (exclusive marketing rights) as requested in their duly motivated request to the TRIPs Council (IP/C/W/605).
To read the letter in full (English, Spanish and French):
CSO letterFinal, CSO letterSP, CSO letterFR
1 comment